Thread and Lokavant have announced a partnership to provide advanced analytics and actionable insights to businesses that operate decentralised clinical trials (DCTs).

Under the partnership, the companies will deploy a clinical operations benchmarking solution to establish industry reference points for DCTs using THREAD.

Sponsors will jointly receive the ability to proactively benchmark trial operational performance against a Lokavant data set of more than 1,300 clinical trials.

This provides increased visibility into trial performance and KPIs that improve outcomes while enhancing the designs of future DCTs.

THREAD CEO John Reites said: “We are excited to pair Lokavant’s unmatched trial insights with THREAD to provide the first data-driven solution focused on improving the performance of decentralised clinical trials.

“This partnership represents THREAD’s commitment to providing differentiated value, quality and performance as we advance global decentralised clinical trial approaches by introducing actionable data.”

Clinical trial execution elements are highlighted by Lokavant Insight through Key Risk Indicators (KRIs) of study health across historical and ongoing clinical trials.

With this, THREAD users can compare trial performance against aggregate and industry standards that currently exist and optimise study planning and execution.

This capability enables researchers to obtain transparency and an ability to make informed decisions to manage DCTs using THREAD.

Lokavant chief business officer Stephanie Lee Griffin said: “Partnering with THREAD expands Lokavant’s ability to offer advanced insights from diverse data sources for the widest range of clinical trial types.

“We’re excited that this partnership offers the industry unprecedented insights and visibility as DCT approaches continue to be rapidly adopted.”

THREAD recently announced a new partnership with CureClick to accelerate recruitment for DCTs.